This review provides a critical and thorough overview of the radiopharmaceutical development
and in vivo evaluation of all apoptosis-detecting radioligands that have emerged so far, …

Tissue hypoxia results from an inadequate supply of oxygen (O 2 ) that compromises biological
functions. Structural and functional abnormalities of the tumour vasculature together with …

The expression of certain bacterial genes is regulated in a cell-density dependent way, a
phenomenon called quorum sensing. Both Gram-negative and Gram-positive bacteria use this …

… f , Guy De Tré PhD d , Luc Belmans MD g , Richard Dobson PhD h , Evelien Wynendaele
PharmD, PhD a , Christophe Van De Wiele MD, PhD i , Filip Vandaele BSc j , Diemer Van Dijck …

Objective The advent of tumor necrosis factor (TNF)–blocking drugs has provided rheumatologists
with an effective, but highly expensive, treatment for the management of established …

Gastrin-releasing peptide (GRP) receptor scintigraphy could allow prediction of response to
GRP receptor-targeted treatment options, early non-invasive diagnosis and in vivo …

Metastatic prostate carcinoma overexpresses prostate-specific membrane antigen (PSMA),
making this antigen a suitable target for radioligand therapy of the disease. Here we report …

Data available in patients suffering from squamous cell carcinoma of the head and neck,
lung carcinoma, oesophageal carcinoma and gynaecological malignancies suggest that …

Objective. Fluorodeoxyglucose (FDG)-positron emission tomography (PET) is an accurate
non-invasive imaging test for differentiating benign from malignant solitary pulmonary nodules …

Cancer patients mount adaptive immune responses against their tumor. However, while
tumor-infiltrating lymphocytes and natural-killer (NK) cells try to detect and eliminate malignant …